Case Number:

IPR2019-01201

Case Type:

IPR

Status:

Final Written Decision

Petitioner:

Illumina, Inc.

Patent Owner:

Natera, Inc.

Tech Center:

1600

1. Filed: June 13, 2019 00:00

   Coverage

   1. September 16, 2020

      Natera Fights Illumina's Bid To Invalidate DNA Testing Patent

      Natera Inc. pushed back Wednesday against Illumina Inc.'s assertions that Natera's patent covering fetal DNA testing technology for detecting Down syndrome was invalid in light of the prior art, contending that Illumina raised an argument during the remote hearing before the Patent Trial and Appeal Board that wasn't in its petition.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login